tiprankstipranks
Trending News
More News >
Scpharmaceuticals (SCPH)
:SCPH
US Market

scPharmaceuticals (SCPH) Income Statement

Compare
Followers

scPharmaceuticals Income Statement

Last quarter (Q2 2025), scPharmaceuticals's total revenue was $16.04M, an increase of 99.17% from the same quarter last year. In Q2, scPharmaceuticals's net income was $-18.02M. See scPharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 36.33M$ 13.59M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 24.97M$ 9.78M$ -468.00K$ -438.00K$ -399.00K
Operating Expenses
$ 89.75M$ 65.18M$ 36.16M$ 25.82M$ 29.93M
Depreciation and Amortization
$ 148.00K$ 626.00K$ 468.00K$ 438.00K$ 399.00K
EBITDA
$ -77.43M$ -46.06M$ -33.07M$ -25.02M$ -29.22M
Operating Income
$ -64.78M$ -55.40M$ -36.16M$ -25.82M$ -29.93M
Other Income/Expenses
$ -20.37M$ 586.00K$ -681.00K$ -2.21M$ -2.28M
Pretax Income
$ -85.15M$ -54.81M$ -36.84M$ -28.03M$ -32.21M
Net Income
$ -85.15M$ -54.81M$ -36.84M$ -28.03M$ -32.21M
Per Share Metrics
Basic EPS
$ -1.91$ -1.42$ -1.30$ -1.02$ -1.31
Diluted EPS
$ -1.91$ -1.42$ -1.30$ -1.02$ -1.31
Weighted Average Shares Outstanding
44.52M 38.51M 28.36M 27.35M 24.57M
Weighted Average Shares Outstanding (Diluted)
44.52M 38.51M 28.36M 27.35M 24.57M
Currency in USD

scPharmaceuticals Earnings and Revenue History